It has recently been shown that CD4 ؉ CD25 ؉ T cells are immunoregulatory T cells that prevent CD4 ؉ T-cell-mediated organ-specific autoimmune diseases. In this study, the regulatory mechanism of CD4 ؉ CD25 ؉ T-cell development were investigated using T-cell receptor (TCR) transgenic mice. It was found that CD4 ؉ CD25 ؉ T cells preferentially expressed the endogenous TCR␣ chain in DO10 ؉ TCR transgenic mice compared with CD4 ؉ CD25 ؊ T cells. Moreover, it was found that CD4 ؉ CD25 ؉ thymocytes were severely decreased in DO10 ؉ TCR-␣ ؊/؊ mice in positively selecting and negatively selecting backgrounds, whereas CD4 ؉ CD25 ؊ thymocytes efficiently developed by transgenic TCR in DO10 ؉ TCR-␣ ؊/؊ mice in positively selecting backgrounds, indicating that the appropriate affinity of TCR to major histocompatibility complex (MHC) for the development of CD4 ؉ CD25 ؉ thymocytes is different from that of CD4 ؉ CD25 ؊ thymocytes and that a certain TCR-MHC affinity is required for the development of CD4 ؉ CD25 ؉ thymocytes. Finally, it was found that, in contrast to thymus, CD4 ؉ CD25 ؉ T cells were readily detected in spleen of DO10 ؉ TCR- 
Introduction
Immunologic tolerance is a feature of the immune system essential for discrimination between self and nonself. Recent data suggest that in addition to clonal deletion and anergy, regulatory T cells play a significant role in the generation and maintenance of tolerance. [1] [2] [3] [4] The term regulatory T cells is used for a variety of immunoregulatory cells that can be subdivided into a number of subsets based on expression of cell surface proteins and pattern of cytokine production. [1] [2] [3] [4] Because these subsets of regulatory T cells have been characterized in experimental models using different assays, the interrelationship between the subsets is difficult to understand. [1] [2] [3] [4] One of the best-characterized subsets of CD4 ϩ regulatory T cells is defined by its constitutive expression of interleukin-2 receptor (IL-2R)-␣ chain (CD25) (CD4 ϩ CD25 ϩ T cells). 3, 4 CD4 ϩ CD25 ϩ T cells constitute approximately 10% of peripheral CD4 ϩ T cells in nonimmunized naive mice and exhibit a broad spectrum of autoimmunity-preventive activity. [5] [6] [7] [8] CD4 ϩ CD25 ϩ T cells are naturally anergic and, on T-cell receptor (TCR)-mediated activation, potently suppress the proliferation of CD4 ϩ CD25 Ϫ T cells by an antigen-nonspecific mechanism. 9-11 Molecular mechanisms by which CD4 ϩ CD25 ϩ T cells mediate suppression are unclear but seem to be independent of cytokine production 9, 10 and dependent on cell contact 9, 10 and to require constitutive expression of CTLA-4. 12, 13 CD4 ϩ CD25 ϩ T cells can be subdivided by the expression pattern of CD45RB high or CD45RB low , CD38 ϩ or CD38 Ϫ , CD69 ϩ or CD69 Ϫ , or CD62L high or CD62L low . 5, 9, 11, 14 Although these findings suggest that CD4 ϩ CD25 ϩ T cells might be heterogeneous and composed of a mixture of regulatory T cells and activated conventional T cells, it has recently been shown that the anergic and suppressive properties of CD4 ϩ CD25 ϩ T cells cannot be subdivided to a smaller subpopulation defined by the expression levels of CD45RB, CD62L, CD38, or CD69. 11, 14 Therefore, CD4 ϩ CD25 ϩ T cells may represent a relatively homogeneous population of regulatory T cells.
Precise signals that promote the development of CD4 ϩ CD25 ϩ T cells remain elusive, but considerable evidence suggests that costimulatory molecules and cytokines play important roles. It has been shown that CD4 ϩ CD25 ϩ T cell levels are severely decreased in mice lacking CD28 8 or CD40L, 15 indicating that signaling by CD28 and by CD40L regulates the number of CD4 ϩ CD25 ϩ T cells in periphery. In addition, CD4 ϩ CD25 ϩ T-cell levels are decreased in mice lacking IL-2 16 or IL-2R component, 17 indicating that IL-2 signaling also regulates the number of CD4 ϩ CD25 ϩ T cells.
The CD25 ϩ population constitutes approximately 5% of CD4 ϩ CD8 Ϫ CD3 high mature thymocytes in normal mice (CD4 ϩ CD25 ϩ thymocytes), and the CD4 ϩ CD25 ϩ thymocytes exhibit a similar functional property to that found in peripheral CD4 ϩ CD25 ϩ T cells. 18 Moreover, thymectomy on day 3 of life decreases the number of CD4 ϩ CD25 ϩ T cells from the peripheral lymphoid organ. 6 Furthermore, CD4 ϩ CD25 ϩ T cells cannot be produced by in vitro culture of CD4 ϩ CD25 Ϫ T cells. 7, 9, 14 Taken together, these findings suggest that CD4 ϩ CD25 ϩ T cells arise in the thymus and migrate to the periphery.
Recently, Itoh et al 18 have shown that CD4 ϩ CD25 ϩ T cells can develop in TCR transgenic mice of wild-type background but not of RAG-2-deficient background. Thus, it is possible that B cells, ␥␦ T cells, or natural killer (NK) T cells, all of which are absent in TCR transgenic RAG-2-deficient mice but are present in TCR transgenic mice, are required for the development of CD4 ϩ CD25 ϩ T cells. It is also possible that the expression of endogenous TCR and the subsequent interaction with self-major histocompatibility complex (MHC) at a certain affinity is required for the development of these cells. However, a great deal of uncertainty remains about differentiation factors and antigen specificity of CD4 ϩ CD25 ϩ T cells.
In the current study, to determine whether positive or negative selection in thymus regulates the development of CD4 ϩ CD25 ϩ T cells, we investigated CD4 ϩ CD25 ϩ T-cell development in mice expressing TCR transgene in positively selecting and negatively selecting MHC backgrounds. We also investigated the requirement of B cells and NK T cells for the development of CD4 ϩ CD25 ϩ T cells. Our results indicate that the size of the CD4 ϩ CD25 ϩ T-cell pool in periphery is regulated at least 2 distinct levels. First, in the thymus, where CD4 ϩ CD25 ϩ T cells are produced, a certain range of TCR-MHC affinity is required for their development. In addition, B cells, but not NK T cells, regulate the expansion and/or survival of CD4 ϩ CD25 ϩ T cells in periphery.
Materials and methods

Mice
BALB/c and C57BL/6 mice were purchased from Japan SLC (Shizuoka, Japan). Immunoglobulin -chain-deficient mice 19 and NK T-cell-deficient mice 20 of C57BL/6 background were previously described. Ovalbuminspecific DO11.10 (DO10 ϩ ) TCR transgenic mice 21 were backcrossed to BALB/c mice for more than 10 generations. BALB/c RAG-2 Ϫ/Ϫ mice 22 were a kind gift from Dr T. Saito (Chiba University). TCR-␣ Ϫ/Ϫ mice 23 Expressions of DO10 ϩ transgene and H-2 haplotypes were determined by fluorescence-activated cell sorter analysis (FACS), as described below. The genotype of TCR-␣ allele was determined by polymerase chain reaction using the following primer pairs: to detect TCR-␣ wild-type allele, 5Ј-aagatcctcggtctcaggacagc-3Ј and 5Ј-ggtaggtggcgttggtctctttg-3Ј; to detect TCR-␣ mutant allele, 5Ј-attcgcagcgcatcgccttctatcg-3Ј and 5Ј-ggtaggtggcgttggtctctttg-3Ј. Homozygosity for the TCR-␣ mutant allele was confirmed, using FACS, by the absence of T cells that express endogenous TCR V-␣2. Mice were housed in micro-isolator cages under pathogen-free conditions; 8-to 10-week-old mice were used in all experiments.
Flow cytometric analysis
Cells from thymus and spleen were stained and analyzed on a FACScalibur (Becton Dickinson, San Jose, CA) using CELLQuest software. For direct staining, the following conjugated antibodies were purchased from PharMingen (San Diego, CA): anti-CD3 fluorescein isothiocyanate (FITC) (145-2C11), anti-CD4 FITC, phycoerythrin (PE), PerCP, allophycocyanin (APC) (H129.19), anti-B220 FITC (RA3-6B2), anti-CD8 FITC, APC (53.6.7), anti-CD25 PE (PC61), anti-CD25 FITC (7D4), anti-CD45RB
, and anti-I-A d FITC (AMS-32.1). KJ1-26 monoclonal antibody, antiidiotype for DO10 TCR, 24 was purified from supernatants of hybridoma cells using protein G columns (Pharmacia, Uppsala, Sweden) and conjugated to FITC or biotin. Before staining, Fc receptors were blocked with anti-CD16/32 antibody (2.4G2; PharMingen).
Annexin V staining
After cells were stained with anti-CD4 APC and anti-CD25 PE and washed twice with phosphate-buffered saline-1% bovine serum albumin, cells were stained with annexin V-FITC (R&D Systems, Minneapolis, MN) according to the manufacturer's instructions. Cells were then analyzed on a FACScalibur.
Data analysis
Data are summarized as mean Ϯ SD. Statistical analysis of the results was performed by the unpaired t test. P Ͻ .05 was considered significant.
Results
CD4 ؉ CD25 ؉ T cells preferentially express the second TCR-␣ chain in TCR transgenic mice
It is well established that allelic exclusion of the TCR-␤ chain is almost perfect, whereas that of the TCR-␣ chain is incomplete. 25 Thus, a considerable fraction of T cells express 2 different TCR-␣␤ pairs. 26 Because it has been shown that CD4 ϩ CD25 ϩ T cells can develop in TCR transgenic mice of wild-type background but not of RAG-2-deficient background, 18 it is possible that CD4 ϩ CD25 ϩ T cells preferentially express the endogenous TCR-␣ chain and that signaling through the endogenous TCR-␣ chain coupled with the transgenic TCR-␤ chain is involved in the development of CD4 ϩ CD25 ϩ T cells in TCR transgenic mice. To examine this possibility, we first investigated the frequency of CD4 ϩ T cells that express both transgenic TCR (recognized by anti-idiotypic monoclonal antibody, KJ1-26) and one of the endogenous TCR V-␣ chains, V-␣2, in the CD25 ϩ or CD25 Ϫ population in ovalbuminspecific TCR transgenic (DO10 ϩ ) mice. As shown in Figure 1A , splenic CD4 ϩ T cells that express transgenic TCR and TCR V-␣2 chain were found at a higher frequency in CD4 ϩ CD25 ϩ T cells than in CD4 ϩ CD25 Ϫ T cells (CD4 ϩ CD25 ϩ T cells 12.0% Ϯ 1.6% versus CD4 ϩ CD25 Ϫ T cells 2.5% Ϯ 1.0%, mean Ϯ SD; n ϭ 5; P Ͻ .001). Moreover, CD4 ϩ T cells that express both transgenic TCR and TCR V-␣11 were also found at a higher frequency in CD4 ϩ CD25 ϩ T cells (data not shown). These results suggest that CD4 ϩ CD25 ϩ T cells preferentially express the second TCR-␣ chain in DO10 ϩ mice. For controls, we performed the same analysis for splenocytes in DO10 ϩ RAG-2-deficient mice. We found that, consistent with the previous report by Itoh et al, 18 CD4 ϩ CD25 ϩ T cells were almost absent in these mice ( Figure 1B ) and that no CD4 ϩ CD25 Ϫ T cell expressed TCR V-␣2 ( Figure 1B) or TCR V-␣11 (data not shown) in these mice.
Dual TCR-␣ expression is not essential for the development of CD4 ؉ CD25 ؉ T cells CD4 ϩ CD25 ϩ T cells preferentially expressed dual TCR-␣ chains in DO10 ϩ mice ( Figure 1A ). To determine whether dual TCR-␣ expression is required for the development of CD4 ϩ CD25 ϩ T cells, we investigated the development of CD4 ϩ CD25 ϩ T cells in TCR-␣ heterozygous mice, in which only one allele of TCR-␣ was available for the expression. As shown in Figure 2 , the number of CD4 ϩ CD25 ϩ T cells in thymus and in spleen was normal in TCR-␣ heterozygous mice, suggesting that though CD4 ϩ CD25 ϩ T cells preferentially expressed the second TCR-␣ chain in TCR transgenic mice, dual TCR-␣ expression was not essential for the development of CD4 ϩ CD25 ϩ T cells. Because CD4 ϩ CD25 ϩ T cells are absent in DO10 ϩ RAG-2 Ϫ/Ϫ mice ( Figure 1B ) and because CD4 ϩ CD25 ϩ T cells preferentially express the second TCR-␣ chain in DO10 ϩ mice ( Figure 1A) , the expression of endogenous TCR-␣ chain and subsequent interaction with self-MHC at an appropriate affinity may be required for the development of CD4 ϩ CD25 ϩ T cells. To test this possibility, we investigated the development of CD4 ϩ CD25 ϩ T cells in DO10 ϩ TCR-␣-deficient (TCR-␣ Ϫ/Ϫ ) mice (Figure 3) . Indeed, the frequency of the CD25 ϩ population in CD4 ϩ CD8 Ϫ mature thymocytes was severely decreased in DO10 ϩ TCR-␣ Ϫ/Ϫ mice with positively selecting H-2 d background compared with that in DO10 ϩ TCR-␣ ϩ/ϩ mice ( Figure 3B ). In contrast, no significant difference was observed in the number of conventional CD4 ϩ CD25 Ϫ mature thymocytes between DO10 ϩ TCR-␣ Ϫ/Ϫ mice and DO10 ϩ TCR-␣ ϩ/ϩ mice ( Figure 3B ). These results indicate that expression of the endogenous TCR-␣ chain is required for the development of CD4 ϩ CD25 ϩ T cells in DO10 ϩ mice. In addition, they indicate that the appropriate affinity of TCR to self-MHC for the development of CD4 ϩ CD25 ϩ thymocytes is different from that of CD4 ϩ CD25 Ϫ thymocytes and that the interaction of TCR with self-MHC at a certain affinity is essential for the development of CD4 ϩ CD25 ϩ thymocytes.
We next analyzed CD4 ϩ CD25 ϩ T-cell development by transgenic TCR in DO10 ϩ mice in a negatively selecting H-2 b background. 27, 28 For this purpose, we investigated DO10 ϩ TCR-␣ Ϫ/Ϫ mice to exclude the effect of endogenous TCR-␣ expression. Interestingly, the number of total thymocytes in DO10 ϩ TCR-␣ Ϫ/Ϫ mice was severely decreased in H-2 b background (DO10 ϩ TCR-␣ Ϫ/Ϫ H-2 b mice compared with DO10 ϩ TCR-␣ Ϫ/Ϫ H-2 d mice; 0.6 Ϯ 0.2 ϫ 10 7 versus 13.2 Ϯ 3.0 ϫ 10 7 ; n ϭ 5 each; P Ͻ .001). Most thymocytes were within the CD4 Ϫ CD8 Ϫ stage ( Figure 3A) ; consequently, the number of CD4 ϩ CD8 Ϫ thymocytes was severely decreased in these mice. When gated on the CD4 ϩ CD8 Ϫ thymocytes that could escape from negative selection in DO10 ϩ TCR-␣ Ϫ/Ϫ mice in H-2 b background, the frequency of the CD25 ϩ population was still severely decreased ( Figure 3B ). These results suggest that CD4 ϩ CD25 ϩ T cells could not develop when the affinity between TCR and MHC was so high.
Interestingly, though the number of CD4 ϩ CD25 ϩ thymocytes was severely decreased in DO10 ϩ TCR-␣ Ϫ/Ϫ mice, CD4 ϩ CD25 ϩ T cells were readily observed in the spleens of DO10 ϩ TCR-␣ Ϫ/Ϫ mice in H-2 d background ( Figure 3C ). The population of CD4 ϩ CD25 ϩ T cells was also approximately 2-fold in the spleens For personal use only. on March 31, 2017 . by guest www.bloodjournal.org From of DO10 ϩ TCR-␣ ϩ/ϩ mice compared with that of CD4 ϩ CD25 ϩ thymocytes ( Figure 3B-C) . Most splenic CD4 ϩ CD25 ϩ T cells in DO10 ϩ TCR-␣ Ϫ/Ϫ mice and DO10 ϩ TCR-␣ ϩ/ϩ mice were of the CD45RB low CD69 Ϫ phenotype, similar to that in wild-type mice (data not shown). These results suggest that there existed some homeostatic machinery that regulated the size of the CD4 ϩ CD25 ϩ T-cell pool in periphery. Figure 3C ) but not in spleens of DO10 ϩ RAG-2 Ϫ/Ϫ mice ( Figure 1B ). Thus, it is possible that a certain population of cells absent in RAG-2-deficient mice regulates the size of the CD4 ϩ CD25 ϩ T-cell pool in periphery. The possibility that B cells might affect CD4 ϩ CD25 ϩ T-cell development was examined by flow cytometric analyses of CD4 ϩ CD25 ϩ T cells in -chaindeficient mice, which lack mature B cells. 19 Interestingly, a profound decrease of splenic CD4 ϩ CD25 ϩ T cells was observed in -chain-deficient mice ( Figure 4A ). Less than 7% of CD4 ϩ T cells in -chain-deficient mice expressed CD25 compared with 13% in wild-type mice (n ϭ 5 each) ( Figure 4A ). Because the absolute number of splenic T cells was decreased in -chain-deficient mice, the number of splenic CD4 ϩ CD25 ϩ T cells was significantly decreased in -chain-deficient mice (approximately 20% of wildtype levels; P Ͻ .001; Figure 4B ). Interestingly, in contrast to splenic CD4 ϩ CD25 ϩ T cells, the number of CD25 ϩ population in CD4 ϩ CD8 Ϫ mature thymocytes was normal in -chain-deficient mice ( Figure 5 ). Taken together, these results indicate that though the development of CD4 ϩ CD25 ϩ T cells in thymus does not require help from B cells, the size of CD4 ϩ CD25 ϩ T-cell pool in periphery is regulated by B cells. In contrast, the number of splenic CD4 ϩ CD25 ϩ T cells (Figure 4 ) and CD4 ϩ CD25 ϩ thymocytes ( Figure 5 ) was normal in NK T cell-deficient mice, indicating that NK T cells are not essential for the development of CD4 ϩ CD25 ϩ T cells.
Discussion
In this study, we show that the size of the peripheral CD4 ϩ CD25 ϩ T-cell pool is regulated by at least 2 distinct mechanisms. First, in the thymus, where CD4 ϩ CD25 ϩ T cells are produced, a certain TCR-MHC affinity is required for the development of CD4 ϩ CD25 ϩ T cells. We found that CD4 ϩ CD25 ϩ T cells preferentially expressed the second TCR-␣ chain in DO10 ϩ TCR transgenic mice ( Figure 1A ) and that the development of CD4 ϩ CD25 ϩ thymocytes was severely impaired in DO10 ϩ TCR-␣ Ϫ/Ϫ mice ( Figure 3B ), indicating that the expression of the endogenous TCR-␣ chain is required for the development of CD4 ϩ CD25 ϩ T cells in TCR transgenic mice. Moreover, we found that CD4 ϩ CD25 ϩ thymocytes were severely decreased in DO10 ϩ TCR-␣ Ϫ/Ϫ mice in the positively selecting background and the negatively selecting background, whereas CD4 ϩ CD25 Ϫ thymocytes effectively developed by transgenic TCR in DO10 ϩ TCR-␣ Ϫ/Ϫ mice in the positively selecting background ( Figure 3B ). Taken together, these results indicate that the appropriate affinity of TCR to self-MHC for the development of CD4 ϩ CD25 ϩ thymocytes is different from that of CD4 ϩ CD25 Ϫ thymocytes and that the interaction of TCR with self-MHC at a certain affinity is essential for the development of CD4 ϩ CD25 ϩ thymocytes. Second, in the periphery, B cells regulate the expansion and/or survival of the developed CD4 ϩ CD25 ϩ T cells. We found that, in contrast to the thymus, CD4 ϩ CD25 ϩ T cells were readily detected in the spleens of DO10 ϩ TCR-␣ Ϫ/Ϫ mice in positively selecting background ( Figure 3C ), suggesting that a small number of CD4 ϩ CD25 ϩ T cells that developed in the thymus might have expanded in the periphery. In addition, we found that the number of splenic CD4 ϩ CD25 ϩ T cells, but not of CD4 ϩ CD25 ϩ thymocytes, was decreased in B-cell-deficient mice (Figures 4, 5) . Therefore, B cells may control the peripheral pool of CD4 ϩ CD25 ϩ T cells, possibly by inducing the expansion or prolonging the survival of these cells.
Although it is accepted that CD4 ϩ CD25 ϩ T cells need activation by TCR for regulatory function, the antigen specificity of CD4 ϩ CD25 ϩ T cells is unknown. We found that CD4 ϩ CD25 ϩ thymocytes were severely decreased in DO10 ϩ TCR-␣ Ϫ/Ϫ mice in negatively selecting H-2 b background (Figure 3) . Moreover, we found that Mtv-9-induced clonal deletion of TCR V-␤5 cells proceeded normally in CD4 ϩ CD25 ϩ T cells in BALB/c mice (data not shown). Furthermore, Papiernik et al 29 have shown that Mls-1 a -induced clonal deletion of TCR V-␤6 cells is also normal in CD4 ϩ CD25 ϩ T cells. These findings indicate that CD4 ϩ CD25 ϩ T cells are not resistant to clonal deletion in thymus. Recently, an altered negative-selection model of CD4 ϩ CD25 ϩ T-cell development was proposed. 3 In this model, the suboptimal stimulation of thymocytes with low-affinity self-antigens would result not in deletion but in a permanent change in TCR signaling. Although we could not identify the TCR-MHC affinity that specifically induced the development of CD4 ϩ CD25 ϩ T cells, identification will extend the understanding of the nature of CD4 ϩ CD25 ϩ T cells.
Although the expression of dual TCR-␣ chain is not essential for the development of CD4 ϩ CD25 ϩ T cells (Figure 2) , CD4 ϩ CD25 ϩ T cells preferentially express the second TCR-␣ chain in DO10 ϩ mice (Figure 1 ). In addition, though transgenic TCR-␣ expression is not sufficient for the development of CD4 ϩ CD25 ϩ T cells in DO10 ϩ mice (Figure 3) , the ligation of transgenic TCR has been shown to be sufficient for the regulatory function of CD4 ϩ CD25 ϩ T cells. 10, 11 These findings suggest that both TCRs on dual TCR-␣-expressing cells are functional for their regulatory activity of CD4 ϩ CD25 ϩ T cells. Therefore, dual TCR-␣ chain expression may increase the chance for TCR signaling of CD4 ϩ CD25 ϩ T cells.
We found that B cells played a significant role in the regulation of the CD4 ϩ CD25 ϩ T-cell pool in the spleen (Figure 4) but not in the development of CD4 ϩ CD25 ϩ T cells in the thymus ( Figure 5 ). Because it has been shown that B7/CD28 interaction 8 and CD40/ CD40L interaction 15 regulate the CD4 ϩ CD25 ϩ T-cell pool in periphery, B cells may regulate the CD4 ϩ CD25 ϩ T-cell pool through B7/CD28 interaction or CD40/CD40L interaction. Recently, it has been shown that the number of dividing cells is modestly increased in CD4 ϩ CD25 ϩ T cells compared with that in CD4 ϩ CD25 Ϫ T cells in periphery. 29 Moreover, we found that apoptotic cells, which were assessed as annexin V binding cells, were not increased in CD4 ϩ CD25 ϩ T cells (data not shown). Thus, it is likely that B cells regulate the cell expansion of CD4 ϩ CD25 ϩ T cells in periphery.
Another subset of CD4 ϩ regulatory T cells, isolated after T cells were activated with alloantigens in the presence of IL-10, was termed type 1 T regulatory (Tr1) cells. 30 Tr1 cells are distinct from classical Th1 or Th2 cells in that they produce large amounts of IL-10 and moderate amounts of transforming growth factor-␤. 30 Significantly, Tr1 cells suppress immune responses in vitro and in vivo through a mechanism dependent on the production of the immunoregulatory cytokine IL-10. 31 In contrast, the regulatory function of CD4 ϩ CD25 ϩ T cells is independent of IL-10 9 . Although it is still possible that they are in fact the same subset of regulatory T cells in different stages of differentiation, the observation that CD4 ϩ CD25 ϩ T cells cannot be differentiated from naive CD4 ϩ CD25 Ϫ T cells in vitro, 7, 9, 14 whereas Tr1 cells can be differentiated from naive cells, 30 favors the hypothesis that CD4 ϩ CD25 ϩ T cells and Tr1 cells are 2 distinct regulatory T cells with similar functions. Moreover, though NK T cells have been shown to be involved in the development of IL-10-dependent regulatory T cells, 32 NK T cells were not required for the development of CD4 ϩ CD25 ϩ T cells (Figures 4, 5) . These observations also support the above hypothesis.
In the past 10 years, a great deal has been learned about the regulation of the CD25 gene. It is known that the CD25 gene has at least 3 important elements for regulation, denoted positively regulatory regions (PRR) I, II, and III. 33 NF-B and SRF bind PRRI, Elf-1 and HMG-I (Y) bind PRRII, and Stat5 and Elf-1 bind PRRIII. 33 Although PRRI is essential for mitogen-antigenmediated induction of the gene and PRRIII is essential for IL-2-induced gene expression, PRRII is essential for transcription in response to either mitogen or IL-2. Thus, the CD25 gene can be controlled not only by activation-dependent signals (NF-B and Stat5) but also by lineage-specific signals (Elf-1). Consistent with these in vitro findings, we found that the CD4 ϩ CD25 ϩ T cells were decreased in both DO10 ϩ TCR-␣ Ϫ/Ϫ mice ( Figure 3 ) and DO10 ϩ Stat5a Ϫ/Ϫ mice, 34 suggesting that both TCR-mediated signaling and Stat5-mediated signaling are required for the development of CD4 ϩ CD25 ϩ T cells in vivo. More detailed mechanisms will be uncovered by promoter analyses of the CD25 gene in CD4 ϩ CD25 ϩ T cells.
In summary, we have shown that the peripheral pool of CD4 ϩ CD25 ϩ T cells is regulated at least 2 distinct levels. First, a certain TCR-MHC affinity is required for the development of CD4 ϩ CD25 ϩ T cells in thymus. Second, B cells are required for the expansion of CD4 ϩ CD25 ϩ T cells in periphery. The identification of TCR-MHC affinity that preferentially induces the development of CD4 ϩ CD25 ϩ T cells will extend our understanding of the nature of CD4 ϩ CD25 ϩ T cells.
Note added in proof. After our submission of this paper to Blood, Jordan et al reported that selection of CD4 ϩ CD25 ϩ thymocytes required a TCR with high affinity for a self-peptide. 35 
